PACB's free cash flow for Q3 2023 was $-66.01M. For the 2023 fiscal year, PACB's free cash flow was decreased by $-168.96M and operating cash flow was $-65.18M. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Operating Cash Flow	$ -266.78M	$ -263.21M	$ -111.18M	$ 19.50M	$ -78.31M	$ -66.43M
Investing Cash Flow	$ 156.18M	$ 116.08M	$ -678.53M	$ -219.32M	$ 62.05M	$ -38.41M
Financing Cash Flow	$ 191.31M	$ 9.62M	$ 1.17B	$ 251.84M	$ 26.55M	$ 107.18M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 830.13M	$ 328.31M	$ 465.82M	$ 85.95M	$ 33.93M	$ 23.64M
Income Tax Paid Supplemental Data	-	-	-	-	-	-
Interest Paid Supplemental Data	$ 14.05M	$ 14.05M	$ 6.93M	$ 491.00K	$ 1.40M	$ 1.40M
Issuance Of Capital Stock	$ 190.45M	$ 11.23M	$ 326.65M	$ 187.48M	$ 8.55M	$ 107.18M
Issuance Of Debt	$ -2.31M	$ -1.61M	$ 895.17M	$ 0.00	-	-
Repayment Of Debt	$ -2.31M	$ -1.61M	$ -361.00K	$ -16.00M	$ 0.00	$ 0.00
Free Cash Flow	$ -278.68M	$ -280.14M	$ -111.18M	$ 18.46M	$ -81.15M	$ -68.28M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Pacific Biosciences Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing